(Q53302536)

13 May 2018

reason for preferred rank

title

High serum hepatocyte growth factor level in patients with non‐Hodgkin's lymphoma (English)

1 reference

https://api.crossref.org/works/10.1034/J.1600-0609.2003.00059.X

23 December 2023

High serum hepatocyte growth factor level in patients with non-Hodgkin's lymphoma (English)

1 reference

PubMed ID

12694163

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694163

23 December 2023

author name string

Liang-Tsai Hsiao

1

1 reference

13 May 2018

Jen-Tsun Lin

2

1 reference

13 May 2018

I-Ting Yu

3

1 reference

13 May 2018

Tzeon-Jye Chiou

4

1 reference

13 May 2018

Jin-Hwang Liu

5

1 reference

13 May 2018

Chueh-Chuan Yen

6

1 reference

13 May 2018

Wei-Shu Wang

7

1 reference

13 May 2018

Po-Min Chen

8

1 reference

13 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

PubMed ID

12694163

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12694163

23 December 2023

publication date

1 May 2003

1 reference

13 May 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1600-0609.2003.00059.x

1 reference

https://api.crossref.org/works/10.1034/J.1600-0609.2003.00059.X

https://onlinelibrary.wiley.com/doi/pdf/10.1034/j.1600-0609.2003.00059.x

23 December 2023

1 reference

https://api.crossref.org/works/10.1034/J.1600-0609.2003.00059.X

European Journal of Haematology

23 December 2023

published in

1 reference

13 May 2018

volume

70

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

282-289

1 reference

13 May 2018

Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors.

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Effect of hepatocyte growth factor on early human haemopoietic cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Detection of serum and intrahepatic human hepatocyte growth factor in patients with type C liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Increase in the circulating level of hepatocyte growth factor in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Hepatocyte growth factor (HGF) protects c-met-expressing Burkitt's lymphoma cell lines from apoptotic death induced by DNA damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Tyrosine kinase receptor indistinguishable from the c-met protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Promyelocytic leukemia cell line, HL-60, produces human hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Significant amount of hepatocyte growth factor detected in blood and bone marrow plasma of leukaemia patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Serum hepatocyte growth factor levels in patients with renal diseases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Measurement of hepatocyte growth factor in serum and plasma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Independent prognostic value of serum hepatocyte growth factor in bladder cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00059.X

7 January 2021

Control of hepatocyte replication by two serum factors

1

1 reference

https://api.crossref.org/works/10.1034/J.1600-0609.2003.00059.X

Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer

23 December 2023

4

1 reference

https://api.crossref.org/works/10.1034/J.1600-0609.2003.00059.X

Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood

23 December 2023

39

1 reference

https://api.crossref.org/works/10.1034/J.1600-0609.2003.00059.X

Serum concentrations of hepatocyte growth factor in breast cancer patients

23 December 2023

41

1 reference

https://api.crossref.org/works/10.1034/J.1600-0609.2003.00059.X

23 December 2023

Identifiers

1 reference

13 May 2018

PubMed ID

12694163

1 reference

13 May 2018